Levoleucovorin

From Wikipedia, the free encyclopedia
Jump to: navigation, search

Levoleucovorin is the enantiomerically active form of Folinic acid.

A study from authors at Georgetown University have shown that there is no safety or efficacy benefit to levoleucovorin.[1]

References[edit]

  1. ^ Kovoor, P. A.; Karim, S. M.; Marshall, J. L. (2009). "Is levoleucovorin an alternative to racemic leucovorin? A literature review". Clinical Colorectal Cancer. 8 (4): 200–6. PMID 19822510. doi:10.3816/CCC.2009.n.034.